Detalles de la búsqueda
1.
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Lancet;
399(10342): 2200-2211, 2022 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35691323
2.
Next-Generation Sequencing-Based Monitoring of Intestinal Bacteria and Bacteriophages Following Fecal Microbiota Transplantation in Inflammatory Bowel Diseases.
Pathogens;
12(12)2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38133321
Resultados
1 -
2
de 2
1
Próxima >
>>